Home > Research > Publications & Outputs > VEGF expression disparities in brainstem motor ...

Links

Text available via DOI:

View graph of relations

VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability. / Silva-Hucha, S.; Fernández de Sevilla, M.E.; Humphreys, K.M. et al.
In: Neurotherapeutics, Vol. 21, No. 3, e00340, 30.04.2024.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Silva-Hucha, S, Fernández de Sevilla, ME, Humphreys, KM, Benson, FE, Franco, JM, Pozo, D, Pastor, AM & Morcuende, S 2024, 'VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability', Neurotherapeutics, vol. 21, no. 3, e00340. https://doi.org/10.1016/j.neurot.2024.e00340

APA

Silva-Hucha, S., Fernández de Sevilla, M. E., Humphreys, K. M., Benson, F. E., Franco, J. M., Pozo, D., Pastor, A. M., & Morcuende, S. (2024). VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability. Neurotherapeutics, 21(3), Article e00340. https://doi.org/10.1016/j.neurot.2024.e00340

Vancouver

Silva-Hucha S, Fernández de Sevilla ME, Humphreys KM, Benson FE, Franco JM, Pozo D et al. VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability. Neurotherapeutics. 2024 Apr 30;21(3):e00340. doi: 10.1016/j.neurot.2024.e00340

Author

Silva-Hucha, S. ; Fernández de Sevilla, M.E. ; Humphreys, K.M. et al. / VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model : Correlations with neuronal vulnerability. In: Neurotherapeutics. 2024 ; Vol. 21, No. 3.

Bibtex

@article{8292c65c389244928d7411a7c19439b0,
title = "VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability",
abstract = "Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease characterized by severe muscle weakness mainly due to degeneration and death of motor neurons. A peculiarity of the neurodegenerative processes is the variable susceptibility among distinct neuronal populations, exemplified by the contrasting resilience of motor neurons innervating the ocular motor system and the more vulnerable facial and hypoglossal motor neurons. The crucial role of vascular endothelial growth factor (VEGF) as a neuroprotective factor in the nervous system is well-established since a deficit of VEGF has been related to motoneuronal degeneration. In this study, we investigated the survival of ocular, facial, and hypoglossal motor neurons utilizing the murine SOD1 G93A ALS model at various stages of the disease. Our primary objective was to determine whether the survival of the different brainstem motor neurons was linked to disparate VEGF expression levels in resilient and susceptible motor neurons throughout neurodegeneration. Our findings revealed a selective loss of motor neurons exclusively within the vulnerable nuclei. Furthermore, a significantly higher level of VEGF was detected in the more resistant motor neurons, the extraocular ones. We also examined whether TDP-43 dynamics in the brainstem motor neuron of SOD mice was altered. Our data suggests that the increased VEGF levels observed in extraocular motor neurons may potentially underlie their resistance during the neurodegenerative processes in ALS in a TDP-43-independent manner. Our work might help to better understand the underlying mechanisms of selective vulnerability of motor neurons in ALS.",
keywords = "ALS, SOD1G93A, Brainstem motor neurons, TDP-43, VEGF, Extraocular system",
author = "S. Silva-Hucha and {Fern{\'a}ndez de Sevilla}, M.E. and K.M. Humphreys and F.E. Benson and J.M. Franco and D. Pozo and A.M. Pastor and S. Morcuende",
year = "2024",
month = apr,
day = "30",
doi = "10.1016/j.neurot.2024.e00340",
language = "English",
volume = "21",
journal = "Neurotherapeutics",
number = "3",

}

RIS

TY - JOUR

T1 - VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model

T2 - Correlations with neuronal vulnerability

AU - Silva-Hucha, S.

AU - Fernández de Sevilla, M.E.

AU - Humphreys, K.M.

AU - Benson, F.E.

AU - Franco, J.M.

AU - Pozo, D.

AU - Pastor, A.M.

AU - Morcuende, S.

PY - 2024/4/30

Y1 - 2024/4/30

N2 - Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease characterized by severe muscle weakness mainly due to degeneration and death of motor neurons. A peculiarity of the neurodegenerative processes is the variable susceptibility among distinct neuronal populations, exemplified by the contrasting resilience of motor neurons innervating the ocular motor system and the more vulnerable facial and hypoglossal motor neurons. The crucial role of vascular endothelial growth factor (VEGF) as a neuroprotective factor in the nervous system is well-established since a deficit of VEGF has been related to motoneuronal degeneration. In this study, we investigated the survival of ocular, facial, and hypoglossal motor neurons utilizing the murine SOD1 G93A ALS model at various stages of the disease. Our primary objective was to determine whether the survival of the different brainstem motor neurons was linked to disparate VEGF expression levels in resilient and susceptible motor neurons throughout neurodegeneration. Our findings revealed a selective loss of motor neurons exclusively within the vulnerable nuclei. Furthermore, a significantly higher level of VEGF was detected in the more resistant motor neurons, the extraocular ones. We also examined whether TDP-43 dynamics in the brainstem motor neuron of SOD mice was altered. Our data suggests that the increased VEGF levels observed in extraocular motor neurons may potentially underlie their resistance during the neurodegenerative processes in ALS in a TDP-43-independent manner. Our work might help to better understand the underlying mechanisms of selective vulnerability of motor neurons in ALS.

AB - Amyotrophic lateral sclerosis (ALS) is a rare neuromuscular disease characterized by severe muscle weakness mainly due to degeneration and death of motor neurons. A peculiarity of the neurodegenerative processes is the variable susceptibility among distinct neuronal populations, exemplified by the contrasting resilience of motor neurons innervating the ocular motor system and the more vulnerable facial and hypoglossal motor neurons. The crucial role of vascular endothelial growth factor (VEGF) as a neuroprotective factor in the nervous system is well-established since a deficit of VEGF has been related to motoneuronal degeneration. In this study, we investigated the survival of ocular, facial, and hypoglossal motor neurons utilizing the murine SOD1 G93A ALS model at various stages of the disease. Our primary objective was to determine whether the survival of the different brainstem motor neurons was linked to disparate VEGF expression levels in resilient and susceptible motor neurons throughout neurodegeneration. Our findings revealed a selective loss of motor neurons exclusively within the vulnerable nuclei. Furthermore, a significantly higher level of VEGF was detected in the more resistant motor neurons, the extraocular ones. We also examined whether TDP-43 dynamics in the brainstem motor neuron of SOD mice was altered. Our data suggests that the increased VEGF levels observed in extraocular motor neurons may potentially underlie their resistance during the neurodegenerative processes in ALS in a TDP-43-independent manner. Our work might help to better understand the underlying mechanisms of selective vulnerability of motor neurons in ALS.

KW - ALS

KW - SOD1G93A

KW - Brainstem motor neurons

KW - TDP-43

KW - VEGF

KW - Extraocular system

U2 - 10.1016/j.neurot.2024.e00340

DO - 10.1016/j.neurot.2024.e00340

M3 - Journal article

C2 - 38472048

VL - 21

JO - Neurotherapeutics

JF - Neurotherapeutics

IS - 3

M1 - e00340

ER -